Cu(II)ATSM: Clinical Trials

3 trials of Cu(II)ATSM, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Unknown 1
Phase 21Unknown 1

Follow Cu(II)ATSM: new trials by email Literature Review of Cu(II)ATSM trials Research Report on Cu(II)ATSM

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ALS Treatment Extension Study
Cu(II)ATSM - Amyotrophic Lateral Sclerosis
Phase 1 / Phase 2UnknownCollaborative Medicinal Development Pty Limited282018-01-182022-02-17
Dose Escalation Study of Cu(II)ATSM in Parkinson's Disease
Cu(II)ATSM - Parkinson Disease
Phase 1CompletedCollaborative Medicinal Development Pty Limited312017-08-142020-03-17
Phase 1 Dose Escalation and PK Study of Cu(II)ATSM in ALS/MND
Cu(II)ATSM - Amyotrophic Lateral Sclerosis, Motor Neuron Disease
Phase 1CompletedCollaborative Medicinal Development Pty Limited502016-11-162020-03-17

Conditions studied

Amyotrophic Lateral Sclerosis (2)  ·  Motor Neuron Disease (1)  ·  Parkinson Disease (1)

Sponsors

Collaborative Medicinal Development Pty Limited (3)

Countries

Australia (3)

Top investigators

Dominic Rowe, MD (2)  ·  Andrew Evans, MD (1)